Johnson & Johnson (JNJ)

Price$232.77

Value ScoreD

Growth ScoreC

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)4.57%

Price vs S&P 500 (4W)5.18%

VGM Score51.71

Market Capitalization$560.33B

P/E Ratio (Annual)20.90x

Indicated Dividend Yield (Annual)2.35%

All Metrics

P/CF (Annual)22.84x

Book Value / Share (Quarterly)$33.73

P/TBV (Annual)16.06x

Indicated Dividend (Annual)$5.36

Revenue Growth (3Y)5.60%

Cash Flow / Share (Quarterly)$7.39

Payout Ratio (TTM)59.52%

Price vs S&P 500 (YTD)4.32%

Gross Margin (TTM)67.95%

Net Profit Margin (TTM)21.83%

EPS (TTM)$8.65

10-Day Avg Trading Volume7.45M

EPS Excl Extra (TTM)$8.65

Revenue Growth (5Y)2.67%

EPS (Annual)$11.03

Dividend / Share (Annual)$5.14

ROI (Annual)20.70%

Gross Margin (Annual)67.98%

Net Profit Margin (5Y Avg)26.91%

Cash / Share (Quarterly)$9.16

P/E Basic Excl Extra (TTM)26.63x

Revenue Growth QoQ (YoY)9.91%

EPS Growth (5Y)14.90%

P/E Normalized (Annual)20.90x

ROA (Last FY)13.46%

Revenue Growth TTM (YoY)7.87%

EBITD / Share (TTM)$13.42

ROE (5Y Avg)31.04%

Operating Margin (TTM)25.88%

Cash Flow / Share (Annual)$8.18

P/B Ratio6.90x

P/B Ratio (Quarterly)7.19x

Net Income / Employee (Annual)$194,000

EV / Revenue (TTM)6.30x

Net Interest Coverage (TTM)34.01x

ROA (TTM)10.70%

EPS Growth QoQ (YoY)-52.82%

EV / EBITDA (TTM)18.57x

EPS Incl Extra (Annual)$11.03

Current Ratio (Annual)1.03x

Quick Ratio (Quarterly)0.69x

3-Month Avg Trading Volume8.13M

52-Week Price Return51.48%

EV / Free Cash Flow (Annual)30.81x

P/E Incl Extra (TTM)26.63x

Revenue / Employee (TTM)$697,300

Tangible BV / Share (Quarterly)$13.35

P/S Ratio (Annual)5.95x

Asset Turnover (Annual)0.47x

52-Week High$251.71

Operating Margin (5Y Avg)23.93%

EPS Excl Extra (Annual)$11.03

CapEx CAGR (5Y)7.62%

Tangible BV CAGR (5Y)25.82%

26-Week Price Return12.49%

Quick Ratio (Annual)0.69x

13-Week Price Return-2.86%

Total Debt / Equity (Annual)0.59x

Current Ratio (Quarterly)1.03x

Enterprise Value$606.92B

Revenue / Share Growth (5Y)4.63%

Asset Turnover (TTM)0.49x

Book Value / Share Growth (5Y)7.10%

Revenue / Employee (Annual)$681,600

Inventory Turnover (Annual)2.27x

Pretax Margin (Annual)34.59%

Cash / Share (Annual)$8.35

3-Month Return Std Dev17.96%

Gross Margin (5Y Avg)69.16%

Net Income / Employee (TTM)$152,200

EBITDA CAGR (5Y)11.06%

EBITDA Interim CAGR (5Y)-3.03%

ROE (Last FY)32.87%

Net Interest Coverage (Annual)35.19x

EPS Basic Excl Extra (Annual)$11.03

P/FCF (TTM)31.51x

Receivables Turnover (TTM)5.71x

EV / Free Cash Flow (TTM)34.13x

Total Debt / Equity (Quarterly)0.68x

EPS Incl Extra (TTM)$8.65

Receivables Turnover (Annual)5.88x

ROI (TTM)16.19%

Dividend Growth Rate (5Y)7.68%

P/S Ratio (TTM)5.81x

Pretax Margin (5Y Avg)23.93%

Revenue / Share (Annual)$38.77

Tangible BV / Share (Annual)$12.93

Forward P/E18.71x

Free OCF CAGR (5Y)-0.49%

Price vs S&P 500 (52W)27.12%

P/E Ratio (TTM)26.63x

EPS Growth TTM (YoY)-3.89%

Year-to-Date Return12.48%

5-Day Price Return4.14%

EPS Normalized (Annual)$11.03

ROA (5Y Avg)12.66%

Net Profit Margin (Annual)28.46%

Month-to-Date Return3.30%

Cash Flow / Share (TTM)$7.61

EBITD / Share (Annual)$16.50

EPS Growth (3Y)17.88%

Operating Margin (Annual)34.59%

LT Debt / Equity (Annual)0.48x

P/CF (TTM)24.50x

ROI (5Y Avg)20.86%

P/E Excl Extra (TTM)26.63x

LT Debt / Equity (Quarterly)0.46x

EPS Basic Excl Extra (TTM)$8.65

P/TBV (Quarterly)18.18x

Payout Ratio (Annual)46.19%

P/B Ratio (Annual)6.13x

Dividend / Share (TTM)$5.20

Inventory Turnover (TTM)2.27x

Pretax Margin (TTM)25.88%

Book Value / Share (Annual)$33.86

Price vs S&P 500 (13W)-11.12%

Net Margin Growth (5Y)9.82%

Dividend Yield (TTM)2.23%

Beta0.24x

P/FCF (Annual)28.45x

Revenue / Share (TTM)$39.41

ROE (TTM)26.26%

52-Week Low$149.04

vGradeD

gGradeC

mGradeB

vgmGradeC

Show chart for

Earnings Surprise History

Q1 262.70est. 2.69

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.78

3.81

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
JNJJohnson & Johnson	D	C	B	$232.77
LLYEli Lilly & Co.	D	B	B	$1131.42
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	B	$34.19

About

Johnson & Johnson is a leading global healthcare company with two core divisions: innovative medicines and medical devices. Following the 2023 divestment of its consumer health business and recent portfolio restructuring, the company concentrates on high-growth therapeutic areas including immunology, oncology, and neurology. Over half of revenue is generated in the United States, with the remainder derived from international markets.